+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell & Gene Therapy Services Market - Global Forecast 2026-2032- Product Image
Cell & Gene Therapy Services Market - Global Forecast 2026-2032- Product Image
Sale

Cell & Gene Therapy Services Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6121485
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell & Gene Therapy Services Market is projected to reach USD 11.46 Billion in 2026. It is expected to continue growing at a CAGR of 16.94%, reaching USD 29.45 Billion by 2032.

Cell and Gene Therapy Services: Executive Overview

Cell and gene therapy services support the discovery, development, manufacturing, testing, regulatory preparation, and lifecycle management of advanced therapies. The field combines highly specialized biology with complex supply chains, strict quality controls, and individualized or small-batch production requirements. Demand is shaped by clinical progress, regulatory experience, manufacturing readiness, and the ability to demonstrate consistent product quality and patient safety.

Specialization and Integration Are Reshaping Service Delivery

The landscape is shifting from discrete outsourced tasks toward integrated development and manufacturing partnerships. Providers increasingly need capabilities spanning vector and cell processing, analytical development, process characterization, clinical logistics, regulatory documentation, and commercial-scale readiness. Standardized platforms are emerging alongside tailored solutions, while automation, closed-system processing, digital batch records, and stronger chain-of-identity controls are helping address variability and operational risk.

Artificial Intelligence Strengthens Quality, Speed, and Decision Support

Artificial intelligence is contributing to target discovery, biomarker analysis, process optimization, image interpretation, deviation investigation, and demand and capacity planning. Machine learning can help identify patterns across complex biological and manufacturing datasets, but its value depends on representative data, validated workflows, explainability, cybersecurity, and human oversight. In regulated settings, AI adoption is therefore most practical when embedded within documented quality systems and supported by auditable data governance.

Regional Dynamics Reflect Uneven Infrastructure and Regulatory Maturity

North America benefits from deep clinical, scientific, investment, and manufacturing capabilities, while Europe combines strong academic networks with increasingly coordinated regulatory and quality expectations. Asia-Pacific is expanding research, clinical, and manufacturing capacity, with China, Japan, South Korea, Australia, and India developing distinct strengths. Latin America is building specialized capabilities from a smaller base and faces challenges involving financing, infrastructure, and cross-border logistics. The Middle East is investing in healthcare modernization and translational research, whereas Africa’s progress is concentrated in selected academic, clinical, and public-health centers, with access and infrastructure remaining important constraints.

Economic and Institutional Groups Shape Collaboration and Access

ASEAN is developing cross-border healthcare and research links, although capabilities differ substantially among member states. BRICS economies provide substantial scientific, manufacturing, and patient resources but operate across varied regulatory and infrastructure environments. The European Union supports regional coordination through common policy frameworks and connected research systems. G7 countries retain leading capabilities in advanced research, regulation, and specialized manufacturing. GCC members are strengthening healthcare investment and localization strategies, while NATO countries benefit from extensive scientific, logistics, and resilience networks, despite differences in national health systems and industrial capacity.

Country-Level Capabilities Show Distinct Strategic Positions

The United States and Canada offer mature research, clinical, regulatory, and manufacturing ecosystems. The United Kingdom, Germany, France, Italy, and Spain contribute strong academic, clinical, and biopharmaceutical capabilities within a connected European environment. China is expanding domestic innovation and production capacity, while Japan and South Korea emphasize high-quality translational research, manufacturing, and regulatory development. India combines a large scientific workforce with growing bioprocessing and clinical capabilities. Australia supports advanced research and clinical activity across a geographically dispersed system. Brazil and Mexico are important Latin American hubs, though infrastructure and access vary. Russia retains scientific and manufacturing capabilities but faces constraints linked to international collaboration, supply chains, and regulatory access.

Prioritize Quality-by-Design, Scalable Platforms, and Resilient Partnerships

Industry leaders should select service partners based on validated technical capabilities, quality-system maturity, inspection readiness, data integrity, and experience with the relevant product modality. Early technical transfer, comparability planning, process characterization, and analytical method development can reduce downstream disruption. Organizations should also diversify critical suppliers, strengthen cold-chain and chain-of-identity controls, establish responsible AI governance, and align regulatory, clinical, manufacturing, and commercial teams from the outset. Regional partnerships and workforce development can improve resilience while supporting broader patient access.

Methodology for a Structured Executive Assessment

This executive summary uses the defined Cell and Gene Therapy Services market scope and organizes the assessment across technology, service delivery, regulation, manufacturing, regional conditions, economic groupings, and country-level capabilities. Insights are framed qualitatively from established sector characteristics and publicly observable patterns in research, clinical development, healthcare infrastructure, and biomanufacturing. The analysis intentionally excludes market estimates, market shares, forecasts, and company-specific claims, and should be supplemented with current primary research when used for investment, sourcing, or policy decisions.

Operational Excellence Will Determine the Next Phase of Cell and Gene Therapy Services

Cell and gene therapy services are moving toward more integrated, data-enabled, and quality-centric operating models. Success will depend less on isolated technical capacity and more on coordinated control of science, manufacturing, regulation, logistics, and patient-specific execution. Leaders that combine validated platforms with flexible expertise, responsible AI adoption, resilient supply networks, and regionally informed partnerships will be better positioned to support safe, efficient, and scalable advancement of these therapies.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell & Gene Therapy Services Market, by Service Type
7.1. Introduction
7.2. Analytical Services
7.2.1. Bioassay
7.2.2. Potency Testing
7.2.3. QC Testing
7.3. Development Services
7.3.1. Clinical Trial Management
7.3.2. Preclinical Development
7.4. Manufacturing Services
7.4.1. Commercial Manufacturing
7.4.2. Process Development
7.4.3. Scale Up
7.5. Regulatory And Consulting Services
7.6. Supply Chain And Logistics
7.6.1. Cold Chain Management
7.6.2. Storage And Distribution
8. Cell & Gene Therapy Services Market, by Technology Platform
8.1. Introduction
8.2. Gene Editing
8.2.1. CRISPR/Cas9
8.2.2. TALEN
8.2.3. ZFN
8.3. Nonviral Delivery
8.3.1. Electroporation
8.3.2. Lipid Nanoparticles
8.4. Viral Vectors
8.4.1. Adeno Associated Virus Vectors
8.4.2. Lentiviral Vectors
8.4.3. Retroviral Vectors
9. Cell & Gene Therapy Services Market, by Therapy Type
9.1. Introduction
9.2. Cell Therapy
9.2.1. CAR-T Cell Therapy
9.2.2. Dendritic Cell Therapy
9.2.3. NK Cell Therapy
9.2.4. Stem Cell Therapy
9.3. Gene Therapy
9.3.1. Ex Vivo Gene Therapy
9.3.2. In Vivo Gene Therapy
10. Cell & Gene Therapy Services Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Biopharma Companies
10.4. Contract Manufacturing Organizations
10.5. Hospitals And Clinics
11. Cell & Gene Therapy Services Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Cell & Gene Therapy Services Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Cell & Gene Therapy Services Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Brammer Bio
15.2. Catalent Inc.
15.3. Charles River Laboratories International, Inc.
15.4. Danaher Corporation
15.5. FUJIFILM Holdings Corporation
15.6. Laboratory Corporation of America Holdings
15.7. Lonza Group AG
15.8. Merck KGaA
15.9. Novasep Holding SAS
15.10. Oxford Biomedica plc
15.11. ReNeuron Group plc
15.12. Sartorius AG
15.13. Takara Bio Inc.
15.14. Thermo Fisher Scientific Inc.
15.15. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cell & Gene Therapy Services Market, Years Considered for the Study
FIGURE 2. Global Cell & Gene Therapy Services Market, Research Design
FIGURE 3. Global Cell & Gene Therapy Services Market, Research Framework
FIGURE 4. Global Cell & Gene Therapy Services Market, Data Triangulation
FIGURE 5. Global Cell & Gene Therapy Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cell & Gene Therapy Services Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global Cell & Gene Therapy Services Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cell & Gene Therapy Services Market Size, by Technology Platform, 2025 vs 2032 (%)
FIGURE 9. Global Cell & Gene Therapy Services Market Size, by Technology Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cell & Gene Therapy Services Market Size, by Therapy Type, 2025 vs 2032 (%)
FIGURE 11. Global Cell & Gene Therapy Services Market Size, by Therapy Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cell & Gene Therapy Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Cell & Gene Therapy Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cell & Gene Therapy Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Cell & Gene Therapy Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cell & Gene Therapy Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Cell & Gene Therapy Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Cell & Gene Therapy Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Cell & Gene Therapy Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cell & Gene Therapy Services Market Segmentation & Coverage
TABLE 2. Global Cell & Gene Therapy Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Analytical Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Analytical Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Analytical Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Bioassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Bioassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Bioassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Potency Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Potency Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Potency Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global QC Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global QC Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global QC Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Development Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Development Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Development Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Clinical Trial Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Clinical Trial Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Clinical Trial Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Preclinical Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Preclinical Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Preclinical Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Manufacturing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Manufacturing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Manufacturing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Commercial Manufacturing Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Commercial Manufacturing Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Commercial Manufacturing Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Process Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Process Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Process Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Scale Up Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Scale Up Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Scale Up Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Regulatory And Consulting Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Regulatory And Consulting Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Regulatory And Consulting Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Supply Chain And Logistics Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Supply Chain And Logistics Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Supply Chain And Logistics Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Cold Chain Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cold Chain Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cold Chain Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Storage And Distribution Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Storage And Distribution Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Storage And Distribution Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 50. Global Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Gene Editing Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global CRISPR/Cas9 Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global CRISPR/Cas9 Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global CRISPR/Cas9 Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global TALEN Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global TALEN Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global TALEN Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global ZFN Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global ZFN Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global ZFN Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Nonviral Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Nonviral Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Nonviral Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Electroporation Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Electroporation Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Electroporation Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Lipid Nanoparticles Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Lipid Nanoparticles Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Lipid Nanoparticles Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Viral Vectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Viral Vectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Viral Vectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Adeno Associated Virus Vectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Adeno Associated Virus Vectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Adeno Associated Virus Vectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Lentiviral Vectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Lentiviral Vectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Lentiviral Vectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Retroviral Vectors Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Retroviral Vectors Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Retroviral Vectors Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 84. Global Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global CAR-T Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global CAR-T Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global CAR-T Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Dendritic Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Dendritic Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Dendritic Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global NK Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global NK Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global NK Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Stem Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Stem Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Stem Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Gene Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Gene Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Gene Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Ex Vivo Gene Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Ex Vivo Gene Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Ex Vivo Gene Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global In Vivo Gene Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global In Vivo Gene Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global In Vivo Gene Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Biopharma Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Biopharma Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Biopharma Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Cell & Gene Therapy Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Cell & Gene Therapy Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. North America Cell & Gene Therapy Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. North America Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 138. North America Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 139. North America Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 140. North America Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 141. North America Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 142. North America Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 143. North America Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 144. North America Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 145. North America Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 146. North America Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 147. North America Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 148. North America Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 149. North America Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. Latin America Cell & Gene Therapy Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Latin America Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 152. Latin America Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 153. Latin America Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 154. Latin America Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 155. Latin America Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 156. Latin America Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 157. Latin America Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 158. Latin America Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 159. Latin America Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 160. Latin America Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 161. Latin America Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 162. Latin America Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 163. Latin America Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Europe Cell & Gene Therapy Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Europe Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 166. Europe Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 167. Europe Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 168. Europe Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 169. Europe Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 170. Europe Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 171. Europe Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 172. Europe Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 173. Europe Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 174. Europe Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 175. Europe Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 176. Europe Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 177. Europe Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Middle East Cell & Gene Therapy Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Middle East Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 180. Middle East Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 181. Middle East Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 182. Middle East Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 183. Middle East Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 184. Middle East Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 185. Middle East Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 186. Middle East Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 187. Middle East Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 188. Middle East Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 189. Middle East Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 190. Middle East Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 191. Middle East Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Africa Cell & Gene Therapy Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Africa Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 194. Africa Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 195. Africa Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 196. Africa Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 197. Africa Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 198. Africa Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 199. Africa Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 200. Africa Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 201. Africa Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 202. Africa Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 203. Africa Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 204. Africa Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 205. Africa Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Global Cell & Gene Therapy Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. ASEAN Cell & Gene Therapy Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. ASEAN Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 209. ASEAN Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 210. ASEAN Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 211. ASEAN Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 212. ASEAN Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 213. ASEAN Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 214. ASEAN Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 215. ASEAN Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 216. ASEAN Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 217. ASEAN Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 218. ASEAN Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 219. ASEAN Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 220. ASEAN Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. GCC Cell & Gene Therapy Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. GCC Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 223. GCC Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 224. GCC Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 225. GCC Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 226. GCC Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 227. GCC Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 228. GCC Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 229. GCC Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 230. GCC Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 231. GCC Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 232. GCC Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 233. GCC Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 234. GCC Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. European Union Cell & Gene Therapy Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. European Union Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 237. European Union Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 238. European Union Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 239. European Union Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 240. European Union Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 241. European Union Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 242. European Union Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 243. European Union Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 244. European Union Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 245. European Union Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 246. European Union Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 247. European Union Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 248. European Union Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. BRICS Cell & Gene Therapy Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. BRICS Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 251. BRICS Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 252. BRICS Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 253. BRICS Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 254. BRICS Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 255. BRICS Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 256. BRICS Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 257. BRICS Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 258. BRICS Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 259. BRICS Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 260. BRICS Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 261. BRICS Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 262. BRICS Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. G7 Cell & Gene Therapy Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 264. G7 Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 265. G7 Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 266. G7 Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 267. G7 Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 268. G7 Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 269. G7 Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 270. G7 Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 271. G7 Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 272. G7 Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 273. G7 Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 274. G7 Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 275. G7 Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 276. G7 Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. NATO Cell & Gene Therapy Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. NATO Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 279. NATO Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 280. NATO Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 281. NATO Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 282. NATO Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 283. NATO Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 284. NATO Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 285. NATO Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 286. NATO Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 287. NATO Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 288. NATO Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 289. NATO Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 290. NATO Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 291. Global Cell & Gene Therapy Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 292. United States Cell & Gene Therapy Services Market Size, 2017-2032 (USD Million)
TABLE 293. United States Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 294. United States Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 295. United States Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 296. United States Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 297. United States Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 298. United States Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 299. United States Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 300. United States Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 301. United States Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 302. United States Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 303. United States Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 304. United States Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 305. United States Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. Canada Cell & Gene Therapy Services Market Size, 2017-2032 (USD Million)
TABLE 307. Canada Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 308. Canada Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 309. Canada Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 310. Canada Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 311. Canada Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 312. Canada Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 313. Canada Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 314. Canada Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 315. Canada Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 316. Canada Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 317. Canada Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 318. Canada Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 319. Canada Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. Mexico Cell & Gene Therapy Services Market Size, 2017-2032 (USD Million)
TABLE 321. Mexico Cell & Gene Therapy Services Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 322. Mexico Cell & Gene Therapy Services Market Size, by Analytical Services, 2017-2032 (USD Million)
TABLE 323. Mexico Cell & Gene Therapy Services Market Size, by Development Services, 2017-2032 (USD Million)
TABLE 324. Mexico Cell & Gene Therapy Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
TABLE 325. Mexico Cell & Gene Therapy Services Market Size, by Supply Chain And Logistics, 2017-2032 (USD Million)
TABLE 326. Mexico Cell & Gene Therapy Services Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 327. Mexico Cell & Gene Therapy Services Market Size, by Gene Editing, 2017-2032 (USD Million)
TABLE 328. Mexico Cell & Gene Therapy Services Market Size, by Nonviral Delivery, 2017-2032 (USD Million)
TABLE 329. Mexico Cell & Gene Therapy Services Market Size, by Viral Vectors, 2017-2032 (USD Million)
TABLE 330. Mexico Cell & Gene Therapy Services Market Size, by Therapy Type, 2017-2032 (USD Million)
TABLE 331. Mexico Cell & Gene Therapy Services Market Size, by Cell Therapy, 2017-2032 (USD Million)
TABLE 332. Mexico Cell & Gene Therapy Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
TABLE 333. Mexico Cell & Gene Therapy Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 334. Brazil Cell & Gene Therapy Services Market Size, 2017-

Companies Mentioned

  • Brammer Bio
  • Catalent Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • FUJIFILM Holdings Corporation
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Merck KGaA
  • Novasep Holding SAS
  • Oxford Biomedica plc
  • ReNeuron Group plc
  • Sartorius AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

Cancer Gene Therapy Market - Global Forecast 2026-2032 - Product Image

Cancer Gene Therapy Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Cell & Gene Therapy Manufacturing Services Market - Global Forecast 2026-2032 - Product Image

Cell & Gene Therapy Manufacturing Services Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Cancer Gene Therapy - Global Strategic Business Report - Product Image

Cancer Gene Therapy - Global Strategic Business Report

  • Report
  • 237 Pages
  • Global
From
Gene Therapy Clinical Trial Services - Global Strategic Business Report - Product Image

Gene Therapy Clinical Trial Services - Global Strategic Business Report

  • Report
  • 414 Pages
  • Global
From
Gene Therapy Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Regions, Leading Players and Sales Forecast - Product Image

Gene Therapy Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Therapeutic Area, Type of Vector, Type of Therapy, Type of Gene Delivery Method, Route of Administration, Geographical Regions, Leading Players and Sales Forecast

  • Report
  • 972 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.